Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

57.59 USD UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 182
Open 57.59
Bid (Size) 57.40 (6)
Ask (Size) 58.00 (5)
Prev. Close 57.59
Today's Range 57.59 - 57.59
52wk Range 56.66 - 69.75
Shares Outstanding 2,222,113,553
Dividend Yield 3.40%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Celebrating the Science That Transforms Patients' Lives
Tags Bristol Myers Squibb Research, Reports & Publications NYSE: BMY
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Dr. Reddy's Laboratories Announces Approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the final approval of its... 
From Business Wire News Releases

Performance

YTD
-6.17%
-6.17%
1 Month
-4.81%
-4.81%
3 Month
-13.68%
-13.68%
6 Month
-12.85%
-12.85%
1 Year
-5.23%
-5.23%

More News

Read More
Team BMS Moves for Minutes to Benefit Special Olympics
Tags Bristol Myers Squibb Team BMS NYSE: BMY
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia (ozanimod) as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis
From Business Wire News Releases
Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
Tags ABBV BLUE AZN
From Motley Fool
Tuesday Talk: Gaining Again
Tags Market News Services Consumer Goods
From TalkMarkets
The Secret To Successful Investing In Biotech
Tags Stocks / Equities Market News Pharma/Biotech
From TalkMarkets
Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Scleros
From Business Wire News Releases
Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today
Tags Market News BMY INFI
From Motley Fool
2 Best Biotech Stocks to Buy Right Now
Tags XLRN Market News BMY
From Motley Fool
2 Top Biotech Stocks to Buy in October
Tags PFE BMY Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.